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ABSTRACT
   We studied acute effects of ethanol (EtOH) 
on the spontaneous locomotor activity in both 
experimentally diabetic (DM) and non-diabetic 
rats. Rats were rendered diabetic by an injection 
of streptozotocin (60 mg/kg).  One-day total 
locomotor activity was significantly decreased in 
DM rats, especially in the dark period, compared 
with that in non-diabetic rats, suggesting that 
diabetes may affect the locomotor activity in rats. 
EtOH (0.5, 1.0, or 2.0 g/kg) was intraperitoneally 
injected and the locomotor activity was measured 
using a running wheel.  All doses (0.5-2.0 g/kg) of 
EtOH tested significantly reduced the spontaneous 
locomotor activity in the dark period in both 
diabetic and non-diabetic rats.  In the dark period, 
the EtOH-induced decrease in locomotor activity 
was more prominent in non-diabetic rats than in 
DM rats.  The peak time of the locomotor activity 
in both rats gradually shifted from the dark to 
light period with increasing doses of EtOH.  It is 
reported that diabetes alters functions of brain 
neurotransmitters, presumably thereby inducing 
the alteration of locomotor activity.  Possible 
involvement of EtOH-induced alterations of 
neurotransmitter system in the brain is discussed.
Key words: ethanol, diabetes mellitus, spontaneous 
locomotor activity, running wheel, rat
INTRODUCTION
   In animals, diabetes mellitus (DM) has been 
reported to be associated with behavioral changes 
(1-4).  Increased retention of passive avoidance 
training in mice (1,3),  enhanced grooming 
activity in a novel environment in rats (2), and 
poor retention of a previously learned avoidance 
response in a T-maze in mice (4) have also been 
reported.  In addition, diabetic rats showed 
significantly more anxiogenic activity than non-
diabetic rats in open-field, elevated plus maze, 
zero maze, and social interaction tests (5).  As with 
locomotion, humans with both type 1 diabetes 
(6) and type 2 diabetes (7) exhibit reduced 
maximal exercise capacity during formal testing. 
Likewise, severe untreated type 1 diabetes in rats 
also reduces spontaneous exercise (8).  In type 1 
diabetic mice, however, it has been reported that 
spontaneous locomotor activity was significantly 
greater than that in non-diabetic mice (9).
   Alcohol is one of the most frequently consumed 
psychoactive drugs in society, despite well-known 
cognitive deficits associated with both acute and 
chronic consumption (10).  The effects of ethanol 
(EtOH) on locomotor activity vary as a function 
of many factors, including animal species, EtOH 
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dosage, and time of assessment during the course 
of acute intoxication (11).  In general, locomotor 
activity in rodents is suppressed after moderate 
or high EtOH doses.  A marked increase in 
spontaneous locomotor activity has been noted 
with relatively low (1-2 g/kg) EtOH doses (12-14), 
while higher doses (>4 g/kg) depress the activity 
(12,15).  Furthermore, a biphasic relationship over 
time is often reported for EtOH-induced activity 
changes, but there is some disagreement over the 
direction of these changes: some studies show 
stimulation followed by depression (13), while 
others show an initial suppression of activity 
followed by stimulation (15).  The effects of EtOH 
on the locomotor activity of rodents, as stated 
above, have been generally evaluated by open-field 
or plus-maze tests.  In the experiments using the 
open-field test, locomotor activities in mice (13,16) 
and rats (17) were unchanged or increased by i.p. 
administration of EtOH (0.5–2.5 g/kg).  Gulick and 
Gould (14) reported that EtOH (1.0–1.4 g/kg) dose-
dependently increased locomotion and decreased 
anxiety and learning in the plus-maze test.
   Evidence is now accumulating that shows a strong 
correlation between alcohol consumption and the 
development of diabetes in both male and female 
human populations (18).  Therefore, the present 
study attempted to ascertain [1] the effects of type 
1 diabetes mellitus on the spontaneous locomotor 
activity in rats, and [2] the acute effects of EtOH 
on spontaneous locomotor activity in the diabetic 
condition, using the rat as the animal species and 
the running wheel as the apparatus measuring 
locomotor activity. In addition, the effects of timing 
(morning or evening) of EtOH-administration were 
examined. Wheel running in rodents has been 
used as a model of physical activity dependence 
(19).  We used streptozotocin (STZ)-treated rats as 
an animal model of type 1 diabetes because STZ 
induces pancreatic β-cell death and hyperglycemia 
associated with decreased insulin secretion (20). 
To the best of our knowledge, no report assessing 
the effects of EtOH on voluntary locomotor activity 
in rats using a running wheel has been published.
MATERIALS AND METHODS
   All experiments described in this report were 
performed in accordance with the specifications 
of the Ethical Committee of Nakamura Gakuen 
University and met the guidelines of the responsible 
governmental agency.
Animals
   Male Wistar rats (4 weeks old) were purchased 
from Kyudo ( Tosu ,  Japan) .  The rats  were 
individually housed in a stainless-steel cage in a 
temperature (22℃)- and humidity (60%)-controlled 
room with a standard 12/12 h light/dark cycle 
(illumination from 7:00 to 19:00).  Rats were 
allowed ad libitum access to food and water. 
The rats were divided into two groups: a control 
group (non-DM rats; n=15) and an experimentally 
diabetic group (DM rats; n=15).  The experimental 
diabetes mellitus was induced by a single injection 
of streptozotocin (STZ, 60 mg/kg, i.p.) dissolved 
in citrate buffer (pH 4.5).  The non-DM rats were 
injected with an equivalent amount of the buffer 
alone.  Diabetes was verified by hyperglycemia, 
glucosuria, and hypoinsulinemia.  The fasting 
blood glucose was measured by a glucose analyzer 
(Glutest Ace, Santa Chemicals, Nagoya, Japan), 
and the fasting blood insulin was measured by an 
insulin analysis kit (Glazyme Insulin-EA Test, Wako, 
Osaka, Japan) after fasting more than 12 hours. 
The rats were used in the experiments at 5-6 weeks 
old, when the body weight, fasting blood glucose, 
and fasting blood insulin values were 162.8 ± 
14.3 g, 82.6 ± 6.7 mg/dl, and 0.978 ± 0.242 ng/
ml in non-DM rats, and 144.9 ± 23.3 g (P=0.078 
vs. non-DM rats), 363.1 ± 117.2 mg/dl (P<0.01 vs. 
non-DM rats), and 0.506 ± 0.069 ng/ml (P<0.05 
vs. non-DM rats) in DM rats, respectively.
Voluntary wheel running
   The behavioral testing protocol is shown in Fig. 
1.  Effects of EtOH on the locomotor activity of rats 
were evaluated by voluntary wheel running.  Rats 
were placed in cages containing a free wheel (KN-
79, Shinano, Tokyo, Japan) for 10 consecutive days 
with free access to food and water. Each revolution 
of the wheel was counted as one by an auto 
counter next to the cage and recorded daily by a 
computer. 
EtOH administration
   EtOH (99.5%) was diluted in 0.9% saline to 
produce solutions of 5%, 10%, and 20% w/v, 
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and was injected i.p. at a constant volume of 0.1 
ml per 10 g body weight to produce doses of 
0.5, 1.0, and 2.0 g/kg, respectively.  EtOH were 
administered in both conditions (beginning time 
of dark period and light period).  Five min prior 
to testing, subjects were injected with either 0.9% 
saline (control condition) or one of the three doses 
of EtOH, according to the experimental schedule 
shown in Fig. 1. First, animals were habituated to 
handling for three consecutive days (Days 1-3 in 
Fig. 1) before testing, which occurred on Day 4. On 
the fourth day, rats were administered 0.9% saline 
(an equivalent volume of the ethanol solution) 
intreaperitoneally (i.p.) at time 19:00 (evening), and 
two days later, on Day 6, ethanol (EtOH) of 0.5 g/
kg was administered at 19:00. Likewise, two days 
later, on Day 8, EtOH of 1.0 g/kg was administered 
at 19:00, and on Day 10 EtOH of 2.0 g/kg was 
administered at 19:00. On Day 5, 7, and 9, rats 
were free.
Blood EtOH determination 
   Blood samples in the presence of antioxidant, 
ascorbic acid (0.1%) were obtained from rats just 
before EtOH injection, and 1 h and 2 h after i.p. 
injection of 0.5 g/kg, 1.0 g/kg, or 2.0 g/kg EtOH. 
Blood EtOH concentrations were determined 
for each dose and time point using an Ethanol 
Assay Kit (BioChain, Hayward, CA, USA), in which 
dichromate is reduced by EtOH to a bluish chromic 
(Cr3＋) product. The intensity of the color, measured 
at 580 nm, is a direct measure of the alcohol 
concentration in the sample.
Drugs
   Ethanol (EtOH) was obtained from Wako Pure 
Chemicals (Osaka, Japan). Streptozotocin (STZ) was 
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Statistical analysis
   Data presented are expressed as means ± S.D. 
Differences were analyzed by Student's t-test and a 
one-way analysis of variance (ANOVA).  P<0.05 was 
considered significant.
RESULTS 
   Blood EtOH concentrations were highest at 1 
h in both DM and non-DM rats (Table 1). The 
blood EtOH concentrations in both rats were 
increased with increasing EtOH dose administered. 
No significant difference in the blood EtOH 
concentration was found in between DM and 
non-DM rats, at least within 2h after EtOH 
administration. 
   Figures 2A, B, C, and D show the effects of i.p. 
injection of saline (control), 0.5 g/kg, 1.0 g/kg, and 
2.0 g/kg EtOH at the beginning time (time 19:00) 
of dark period on the 24-h locomotion in both 
DM and non-DM rats, respectively.  The data are 
expressed as the locomotor activity per hour, and 
are mean ± SD of 9 rats, respectively.  In general, 
the locomotor activity of rats was higher during 
the dark period (time 19:00–7:00), but lower 
during the light period (time 7:00–19:00), because 
rats are nocturnal.  In the control condition (saline 
administration) (panel A), the locomotor activity of 
non-DM rats during the dark period was more than 
twice that during the light period.  However, the 
locomotor activity of DM rats was generally lower 
Days 1-3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10
Habituation Equivolumesaline i.p. rest
EtOH 
(0.5g/kg) i.p. rest
EtOH 
(1.0g/kg) i.p. rest
EtOH
(2.0g/kg) i.p.
Fig. 1
Dosing schedule for ethanol (EtOH)-induced locomotor activity. Both diabetic (DM) and non-diabetic (non-
DM) rats were habituated to handling for three consecutive days (Days 1-3).  On the fourth day, rats were 
administered 0.9% saline (an equivalent volume to the EtOH solution) i.p at 19:00, and two days later, on 
Day 6, EtOH of 0.5 g/kg was administered at 19:00. Likewise, two days later, on Day 8, EtOH of 1.0 g/kg was 
administered, and on Day 10 EtOH of 2.0 g/kg was administered at the same time. On Day 5, 7, and 9, rats 
were untreated.
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Table 1
Table 1
Blood EtOH concentrations in both DM and non-DM rats
non-DM rat EtOH 0hr 1hr 2hr
0.5 g/kg 81.6±10.9 mg/dl 78.5±17.9 mg/dl 63.6±9.0 mg/dl
1.0 80.4±11.3 118.2±6.0♭ 113.5±30.1
2.0 74.7±12.2 172.1±12.8***### 149.4±15.9**###
DM rat EtOH 0hr 1hr 2hr
0.5 g/kg 100.1±32.4 mg/dl 92.5±28.4 mg/dl 68.7±49.9 mg/dl
1.0 87.4±20.3 118.8±30.6 93.5±36.4
2.0 67.9±23.2 140.0±44.0## 129.4±23.1#
Data are expressed as means±S.D.
** P<0.01 vs. 2hr at EtOH 0.5 g/kg, *** P<0.001 vs. 1hr at EtOH 0.5 g/kg
# P<0.05, ## P<0.01, ### P <0.001 vs. 0 hr at EtOH 2.0 g/kg
♭P<0.05 vs. 1 hr at EtOH 0.5 g/kg
than that of non-DM rats. 
   EtOH at 0.5 g/kg markedly decreased the total 
24-h locomotor activity in both DM and non-DM 
rats.  The decrease was more evident in non-DM 
rats. EtOH at 1.0 or 2.0 g/kg further affected the 
locomotion in both rats (panels C and D).  The peak 
locomotor activity in both rats gradually shifted 
from the dark period to the light period with 
increasing doses of EtOH.
   The effects of all three EtOH dosages (0.5, 1.0, 
and 2.0 g/kg) tested on locomotor activity all day, 
during the dark period alone, and during the light 
period alone are summarized in Fig. 3. Panels A, 
B, and C show the actual locomotor activity data 
(number of counts), but panels D, E, and F show 
the normalized data, taking the data of the control 
condition (saline), shown in panels A, B, and C as 
100%.  As stated before, the all-day locomotor 
activities of DM and non-DM rats were markedly 
suppressed in the presence of all dosages of EtOH, 
especially in non-DM rats.  When all-day locomotor 
activity was divided into the locomotor activities of 
dark and light periods, EtOH dominantly affected 
the locomotor activity of both DM and non-DM rats 
in the dark period (panels B, C, E and F).
DISCUSSION
   In this study, we tried to clarify the effects of 
[1] type 1 diabetes mellitus on locomotor activity 
using a running wheel, and [2] EtOH on locomotor 
activity in rats with and without STZ-induced 
diabetes.  Further, to what degree does the diabetic 
state affect EtOH-induced alterations in locomotor 
activity?
   As shown in Figs. 2A and 3, type 1 diabetes 
significantly reduced total locomotor activity in 24 
hours, as observed by use of the running wheel, 
especially in the dark period, which is the active 
time for rats.  However, in the light period which 
is thought to be equivalent to rest (sleeping) time, 
little difference was found between DM and non-
DM rats in locomotor activity (Fig. 3C).  That is, 
DM rats have less locomotor activity during the 
dark period than non-DM rats.  This is in good 
agreement with the results of Van Lunteren et 
al.  (8) They also used STZ-induced DM rats and 
a running wheel to measure locomotor activity. 
The daily running distance of DM rats was only 
about 4% of the controls.  Further, Merali et al. 
(21) observed decreased floor activity during the 
dark period in spontaneously diabetic Wistar BB 
rats, and Hilakivi-Clarke et al.  (22) also reported 
lowered locomotor activity in STZ-diabetic mice as 
measured by a holeboard test. 
   In humans,  60-70% of diabet ic pat ients 
develop neuropathy (23).  Sensorimotor diabetic 
polyneuropathy affects both large and small 
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sensory afferent nerve fibers.  In fact, abnormal 
muscle spindle innervation and large-fiber 
neuropathy were observed in STZ-induced 
diabetic mice (9).  These findings suggest that 
the reduced locomotor activity observed in the 
present study might be associated with diabetes-
induced neuropathy.  In contrast, however, STZ-
induced diabetic mice showed increased locomotor 
activity as measured by an ambulometer (24, 25). 
Kamei et al.  (24) suggested that this enhanced 
spontaneous locomotor activity in diabetic 
mice may result from increased dopamine (DA) 
neurotransmission, which might be due to an 
increase in DA release in the mesolimbic DA 
system.  The resultant differences between our 
experiment and the experiments by Kamei et al. 
might be due the differences in animal species, 
severity of diabetic state, and/or apparatus used to 
measure locomotor activity.  Uncontrolled diabetes 
mellitus causes abnormalities of the daily temporal 
variations of several behavioral and physiological 
processes in both humans (26) and rodents (27-
29).  In the present study, the locomotor activity 
in the dark period was significantly reduced by 
the diabetic state, while the locomotor activity 
in the light period was almost unchanged.  This 
finding suggests that diabetes may affect, at least 
in part, the circadian rhythm of locomotion in 
rats.  Studies of the endocrine rhythms in diabetic 
rodents reveal that daily variations of plasma 
corticosterone can be either phase advanced (27) 
or masked by continuous hypercorticosteronemia 
(28).  The locomotor activity rhythm of DM rats 
exhibits an advanced phase angle of entrainment 
(28) as well as a decreased amplitude (28, 29).  In 
mice, abnormalities of daily temporal organization 
associated with diabetes can result from altered 
circadian responses to the daily variation in 
ambient light (30).
   Acute administration of EtOH (0.5-2.0 g/kg) 
obviously decreased the spontaneous locomotor 
activity in both DM and non-DM rats.  The decrease 
in locomotor activity was greater in the dark 
period than in the light period, although this may 
be due to the decreased concentration of blood 
EtOH in the light period than in the dark period 
by the metabolism of EtOH.  The peak time of the 
locomotor activity in both rats gradually shifted 
from the dark to the light period with increasing 
EtOH dose (Fig. 2).  Acute EtOH selectively 
attenuates the phase-shifting effects of late-night 
light pulses in hamsters (31). 
   A close relationship between neurotransmitters 
and specific behavioral and other effects of EtOH 
has been observed in many studies.  EtOH modifies 
neural function and thereby produces intoxication, 
memory  impa i rment ,  re in forcement ,  and 
dependence.  In vivo microdialysis data from our 
laboratory show that acute administration of EtOH 
(0.5-2.0 g/kg) significantly increased serotonin 
release from rat hippocampus dose-dependently 
(32).  Alterations in brain neurotransmitter systems 
will, as a matter of course, cause alterations in 
behavioral activity.  Pastor and Aragon (33) have 
reported that injection of EtOH (64-256 μg) 
into the hypothalamic arcuate nucleus induces 
behavioral stimulation in rats.
   Differential effects of EtOH on locomotor activity 
between DM and non-DM rats were observed. 
Namely, during the dark period, the EtOH-induced 
decrease in locomotor activity was more prominent 
in non-DM rats than in DM rats.  This may not be 
due to the difference of the metabolizing process 
of EtOH in between DM and non-DM rats, because 
the blood EtOH concentrations in DM rats at 
1 and 2 h after EtOH administration were not 
significantly different from those in non-DM rats. 
The present study is the first, to our knowledge, to 
compare the acute effects of EtOH administration 
on the locomotor activity of DM and non-DM rats. 
Diabetes is associated with several behavioral 
changes in animals.  We previously reported 
significant decreased level of serotonin in the 
hippocampus of diabetic rats (34).  Therefore, the 
findings in the present study might be, at least in 
part, related to changed level of neurotransmitters 
in diabetic brain. 
CONCLUSION
   The present results indicate that type 1 diabetes 
mellitus significantly reduced total 24-hour 
locomotor activity as observed on the running 
wheel.  The decrease in locomotor activity was 
more evident during the dark period than during 
the light period.  Next, acute administration of 
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EtOH (0.5-2.0 g/kg) significantly decreased the 
spontaneous locomotor activity in the dark period 
in both DM and non-DM rats.  However, during 
the dark period, the EtOH-induced decrease in 
locomotor activity was more prominent in non-
DM rats than in DM rats.  Recently, attention has 
been directed towards the detrimental effects of 
type 1 diabetes on the central nervous system, and 
the results suggest that altered functions of brain 
neurotransmitters may be involved.
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